NM_001042413.2:c.2159G>A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001042413.2(GLIS3):c.2159G>A(p.Arg720Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000502 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001042413.2 missense
Scores
Clinical Significance
Conservation
Publications
- neonatal diabetes mellitus with congenital hypothyroidismInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001042413.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLIS3 | NM_001042413.2 | MANE Select | c.2159G>A | p.Arg720Gln | missense | Exon 8 of 11 | NP_001035878.1 | ||
| GLIS3 | NM_001438906.1 | c.2159G>A | p.Arg720Gln | missense | Exon 8 of 11 | NP_001425835.1 | |||
| GLIS3 | NM_001438907.1 | c.2159G>A | p.Arg720Gln | missense | Exon 8 of 11 | NP_001425836.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GLIS3 | ENST00000381971.8 | TSL:5 MANE Select | c.2159G>A | p.Arg720Gln | missense | Exon 8 of 11 | ENSP00000371398.3 | ||
| GLIS3 | ENST00000324333.14 | TSL:1 | c.1694G>A | p.Arg565Gln | missense | Exon 7 of 10 | ENSP00000325494.10 | ||
| GLIS3 | ENST00000467497.6 | TSL:1 | n.699G>A | non_coding_transcript_exon | Exon 5 of 6 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152042Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000155 AC: 39AN: 251134 AF XY: 0.000147 show subpopulations
GnomAD4 exome AF: 0.0000472 AC: 69AN: 1461842Hom.: 0 Cov.: 32 AF XY: 0.0000536 AC XY: 39AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74386 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Inborn genetic diseases Uncertain:1
The c.1694G>A (p.R565Q) alteration is located in exon 7 (coding exon 6) of the GLIS3 gene. This alteration results from a G to A substitution at nucleotide position 1694, causing the arginine (R) at amino acid position 565 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Neonatal diabetes mellitus with congenital hypothyroidism Uncertain:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at